Equities

Scisparc Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SPRC:NAQ

Scisparc Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5964
  • Today's Change-0.001 / -0.15%
  • Shares traded52.69k
  • 1 Year change-94.63%
  • Beta1.2732
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at Scisparc Ltd fell by 536.00k. Cash Flow from Financing totalled 6.19m or 474.20% of revenues. In addition the company used 5.10m for operations while cash used for investing totalled 1.63m.
Cash flow per share--
Price/Cash flow per share--
Book value per share-1.46
Tangible book value per share-4.05
More ▼

Balance sheet in USDView more

Scisparc Ltd has a Debt to Total Capital ratio of 103.99%.
Current ratio0.5457
Quick ratio0.5151
Total debt/total equity--
Total debt/total capital1.04
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.